Stryker Corp
NYSE:SYK
Stryker Corp
Operating Income
Stryker Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Operating Income
$1.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Stryker Corp's Operating Income?
Operating Income
4.5B
USD
Based on the financial report for Mar 31, 2024, Stryker Corp's Operating Income amounts to 4.5B USD.
What is Stryker Corp's Operating Income growth rate?
Operating Income CAGR 10Y
7%
Over the last year, the Operating Income growth was 17%. The average annual Operating Income growth rates for Stryker Corp have been 17% over the past three years , 7% over the past five years , and 7% over the past ten years .